Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection

Direct-acting antiviral agents (DAAs) that allow for rapid clearance of hepatitis C virus (HCV) may evoke immunological changes. Some cases of rapid de novo hepatocellular carcinoma (HCC) development or early recurrence of HCC after DAA treatment have been reported. During chronic HCV infection, nat...

Full description

Bibliographic Details
Main Authors: Pil Soo Sung, Eui-Cheol Shin
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
hepatitis C virus
hepatocellular carcinoma
direct-acting antivirals
Online Access:https://www.mdpi.com/2077-0383/10/2/221

Internet

https://www.mdpi.com/2077-0383/10/2/221

Similar Items